Efgartigimod Alfa + Ravulizumab Interaction
Moderateinteraction on record
Description
Neonatal Fc receptor blocker that may lower systemic exposures and reduce effectiveness of ULTOMIRIS; closely monitor for reduced effectiveness.
Mechanism
Lowers systemic exposures of ravulizumab
Source: NLP:ravulizumab